Mechanisms of Action for Treatments in Multiple Sclerosis: Does a Heterogeneous Disease Demand a Multi-Targeted Therapeutic Approach?

Author： Chofflon Michel

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.19, Iss.5, 2005-01, pp. : 299-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Parkinson's Disease Have an Immunological Basis?: The Evidence and its Therapeutic Implications

By Fiszer U.

BioDrugs, Vol. 15, Iss. 6, 2001-06 ,pp. : 351-355

Adis International

Access to resources Recommend Favorite

Recombinant Interferon- -1a: A Review of its Therapeutic Efficacy in Relapsing-Remitting Multiple Sclerosis

By Wagstaff A.J. Goa K.L.

BioDrugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 471-494

Adis International

Access to resources Recommend Favorite

Therapeutic Approaches to Multiple Sclerosis: An Update on Failed, Interrupted, or Inconclusive Trials of Neuroprotective and Alternative Treatment Strategies

By Meuth Sven G. Bittner Stefan

BioDrugs, Vol. 24, Iss. 5, 2010-10 ,pp. : 317-330

Adis International

Access to resources Recommend Favorite

Therapeutic Approaches to Multiple Sclerosis: An Update on Failed, Interrupted, or Inconclusive Trials of Immunomodulatory Treatment Strategies

By Ulzheimer Jochen C. Meuth Sven G. Bittner Stefan

BioDrugs, Vol. 24, Iss. 4, 2010-08 ,pp. : 249-274

Adis International

Access to resources Recommend Favorite

Targeting of Costimulatory Molecules as a Therapeutic Approach in Inflammatory Bowel Disease

By Maerten P.

BioDrugs, Vol. 17, Iss. 6, 2003-01 ,pp. : 395-411

Adis International

Access to resources Recommend Favorite